Clinical Trial Update: A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) [Phase 2]

View source ↗

Summary

Phase 2 dose confirmation and pharmacokinetic study of pegcrisantaspase given IV in children and young adults with acute lymphoblastic leukemia or lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Pegcrisantaspase (Pegcrisantaspase)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-02-23